Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. | 14,589,846 | reported | 10 Oct 2025 | tx 1+784,720 |
| Eidos Therapeutics, Inc. | 1,000 | reported | 26 Jan 2021 | tx 3+16,415,037 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Oct 2025 | OTHER | BridgeBio Oncology Therapeutics, Inc. | 784,720 | — | |
| 26 Jan 2021 | PURCHASE | Eidos Therapeutics, Inc. | 14,428,836 | — | first after silence |
| 03 Jul 2019 | PURCHASE | Eidos Therapeutics, Inc. | 882,353 | 29.90 USD | |
| 24 May 2019 | PURCHASE | Eidos Therapeutics, Inc. | 1,103,848 | 25.93 USD |
1 purchase reported after at least 12 months of silence — most recent on 26 Jan 2021.